Regulatory Affairs and Oncology professional, Kamesh Kuchimanchi, is on a mission to bring life-saving medications and treatments to patients in need.
Executive Director of Regulatory Affairs
Since 2018, Kamesh Kuchimanchi has represented Boston Biomedical Inc.’s Sumitomo Dainippon Global Oncology Unit as Executive Director of Regulatory Affairs. As such, his responsibilities include:
- Managing, mentoring, and guiding members of the regulatory affairs team
- Managing, mentoring, and guiding members of the regulatory affairs team
- Providing strategic guidance for development programs and activities
Through his role as Executive Director, Kuchimanchi has executed complex study design changes in accordance with the FDA (CDER) regarding a phase 3 study on colorectal cancer indication. The research conducted by Kuchimanchi and his fellow team members aims to both change and save lives. The ultimate goal of this research is to gain new perspectives on different forms of cancer and developing medications. Through his work, Kuchimanchi is assisting the medical world in the development of truly life-saving treatments.
Affiliations & Awards
Kamesh Kuchimanchi is a member of the American Society for Clinical Oncology (ASCO). Balancing on the cutting edge in his own professional work, Kuchimanchi takes full advantage of the resources presented by his ASCO membership. He particularly enjoys networking with other oncology professionals and cancer physicians. The conferences, professional workshops and scientific meetings hosted by ASCO offer members incredible learning opportunities.
Over the past twenty years, Kamesh Kuchimanchi has received various awards and recognitions for his work in oncology and regulatory affairs. Notable achievements include:
- Quintiles Outstanding Customer Service Award (2001)
- Amgen Development Hall of Fame Star Awards (2005 & 2006)
- Baxter PM Excellence Award (2007)
- Baxter Emerging Leader Recognition (2013)
- Baxalta Oncology Division Spark of Success Award (2015)
- Shire Oncology Leadership Award (2016)
In the coming years, Kamesh Kuchimanchi anticipates major developments in the world of cancer research. As a member of the Sumitomo Dainippon Global Oncology Unit team, Kuchimanchi is determined to contribute to research and developments that will truly change the lives of oncology patients for the better!
Submit your review | |
